Perspective | Published:

Microfluidic organs-on-chips

Nature Biotechnology volume 32, pages 760772 (2014) | Download Citation

Abstract

An organ-on-a-chip is a microfluidic cell culture device created with microchip manufacturing methods that contains continuously perfused chambers inhabited by living cells arranged to simulate tissue- and organ-level physiology. By recapitulating the multicellular architectures, tissue-tissue interfaces, physicochemical microenvironments and vascular perfusion of the body, these devices produce levels of tissue and organ functionality not possible with conventional 2D or 3D culture systems. They also enable high-resolution, real-time imaging and in vitro analysis of biochemical, genetic and metabolic activities of living cells in a functional tissue and organ context. This technology has great potential to advance the study of tissue development, organ physiology and disease etiology. In the context of drug discovery and development, it should be especially valuable for the study of molecular mechanisms of action, prioritization of lead candidates, toxicity testing and biomarker identification.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    The outgrowth of the nerve fiber as a mode of protoplasmic movement. J. Exp. Zool. 9, 787–846 (1910).

  2. 2.

    & Systematic reviews of animal models: methodology versus epistemology. Int. J. Med. Sci. 10, 206–221 (2013).

  3. 3.

    & The growth of cells on a transparent gel of reconstituted rat-tail collagen. J. Natl. Cancer Inst. 16, 1375–1403 (1956).

  4. 4.

    & Three-dimensional cultures of mouse mammary epithelial cells. Methods Mol. Biol. 945, 221–250 (2013).

  5. 5.

    & Growing self-organizing mini-guts from a single intestinal stem cell: mechanisms and applications. Science 340, 1190–1194 (2013).

  6. 6.

    et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373–379 (2013).

  7. 7.

    et al. Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells. Cancer Cell 21, 227–239 (2012).

  8. 8.

    , & Mechanobiology and developmental control. Annu. Rev. Cell Dev. Biol. 29, 27–61 (2013).

  9. 9.

    Mechanobiology and diseases of mechanotransduction. Ann. Med. 35, 564–577 (2003).

  10. 10.

    , , & Rapid prototyping of microfluidic systems in poly(dimethylsiloxane). Anal. Chem. 70, 4974–4984 (1998).

  11. 11.

    et al. Engineering cell shape and function. Science 264, 696–698 (1994).

  12. 12.

    , , , & Geometric control of cell life and death. Science 276, 1425–1428 (1997).

  13. 13.

    & Cellular micropatterns on biocompatible materials. Biotechnol. Prog. 14, 388–392 (1998).

  14. 14.

    , , , & Patterning proteins and cells using soft lithography. Biomaterials 20, 2363–2376 (1999).

  15. 15.

    , , , & Molding of deep polydimethylsiloxane microstructures for microfluidics and biological applications. J. Biomech. Eng. 121, 28–34 (1999).

  16. 16.

    et al. Fabrication of two-layered channel system with embedded electrodes to measure resistance across epithelial and endothelial barriers. Anal. Chem. 82, 2505–2511 (2010).

  17. 17.

    , , & Microfluidic chip with integrated electrical cell-impedance sensing for monitoring single cancer cell migration in three-dimensional matrixes. Anal. Chem. 85, 11068–11076 (2013).

  18. 18.

    et al. Electrofluidic pressure sensor embedded microfluidic device: a study of endothelial cells under hydrostatic pressure and shear stress combinations. Lab Chip 13, 1743–1753 (2013).

  19. 19.

    et al. Metabolic discrimination of select list agents by monitoring cellular responses in a multianalyte microphysiometer. Sensors (Basel) 9, 2117–2133 (2009).

  20. 20.

    et al. Subcellular positioning of small molecules. Nature 411, 1016 (2001).

  21. 21.

    et al. Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat. Biotechnol. 20, 826–830 (2002).

  22. 22.

    et al. Biased migration of confined neutrophil-like cells in asymmetric hydraulic environments. Proc. Natl. Acad. Sci. USA 110, 21006–21011 (2013).

  23. 23.

    , , & Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am. J. Physiol.Heart Care Physiol. 288, H1278–H1289 (2005).

  24. 24.

    et al. Simultaneous generation of gradients with gradually changed slope in a microfluidic device for quantifying axon response. Anal. Chem. 85, 7842–7850 (2013).

  25. 25.

    , , , & A microfluidic cell culture array with various oxygen tensions. Lab Chip 13, 3239–3245 (2013).

  26. 26.

    et al. Microfluidic device generating stable concentration gradients for long term cell culture: application to Wnt3a regulation of betacatenin signaling. Lab Chip 10, 3277–3283 (2010).

  27. 27.

    et al. A microfluidic-based neurotoxin concentration gradient for the generation of an in vitro model of Parkinson's disease. Biomicrofluidics 5, 22214 (2011).

  28. 28.

    & Non-invasive microfluidic gap junction assay. Integr. Biol. (Camb) 2, 130–138 (2010).

  29. 29.

    et al. In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomed. Microdevices 10, 795–805 (2008).

  30. 30.

    et al. BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed. Microdevices 15, 145–150 (2013).

  31. 31.

    , & An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol. Bioeng. 97, 1340–1346 (2007).

  32. 32.

    et al. Patterned deposition of cells and proteins onto surfaces by using three dimensional microfluidic systems. Proc. Natl. Acad. Sci. USA 97, 2408–2413 (2000).

  33. 33.

    , , & Liver-specific functional studies in a microfluidic array of primary mammalian hepatocytes. Anal. Chem. 78, 4291–4298 (2006).

  34. 34.

    et al. High-throughput combinatorial cell co-culture using microfluidics. Integr. Biol. (Camb) 3, 653–662 (2011).

  35. 35.

    , , , & Microfluidic heart on a chip for higher throughput pharmacological studies. Lab Chip 13, 3599–3608 (2013).

  36. 36.

    et al. On chip porous polymer membranes for integration of gastrointestinal tract epithelium with microfluidic 'body-on-a-chip' devices. Biomed. Microdevices 14, 895–906 (2012).

  37. 37.

    , , , & Microfluidics embedded within extracellular matrix to define vascular architectures and pattern diffusive gradients. Lab Chip 13, 3246–3252 (2013).

  38. 38.

    et al. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. Proc. Natl. Acad. Sci. USA 110, 6712–6717 (2013).

  39. 39.

    et al. A versatile assay for monitoring in vivo-like transendothelial migration of neutrophils. Lab Chip 12, 3861–3865 (2012).

  40. 40.

    , , , & Ischemia/reperfusion injury of primary porcine cardiomyocytes in a lowshear microfluidic culture and analysis device. Analyst (Lond.) 136, 3519–3526 (2011).

  41. 41.

    et al. Probing functional properties of nociceptive axons using a microfluidic culture system. PLoS ONE 8, e80722 (2013).

  42. 42.

    , , & Flow-based pipeline for systematic modulation and analysis of 3D tumor microenvironments. Lab Chip 13, 1969–1978 (2013).

  43. 43.

    & Incorporation of 3T3–L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies. Biotechnol. Prog. 20, 590–597 (2004).

  44. 44.

    et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662–1668 (2010).

  45. 45.

    et al. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci. Transl. Med. 4, 159ra147 (2012).

  46. 46.

    & A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. Lab Chip 10, 36–42 (2010).

  47. 47.

    & Characterization of a microfluidic in vitro model of the blood-brain barrier (mBBB). Lab Chip 12, 1784–1792 (2012).

  48. 48.

    , , & Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12, 2165–2174 (2012).

  49. 49.

    & Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr Biol (Camb) 5, 1130–1140 (2013).

  50. 50.

    et al. Chip-based comparison of the osteogenesis of human bone marrow- and adipose tissue-derived mesenchymal stem cells under mechanical stimulation. PLoS ONE 7, e46689 (2012).

  51. 51.

    , & In vitro electrical-stimulated wound-healing chip for studying electric field-assisted wound healing process. Biomicrofluidics 6, 34117 (2012).

  52. 52.

    , & Differentiation of embryonic stem cells into cardiomyocytes in a compliant microfluidic system. Ann. Biomed. Eng. 39, 1840–1847 (2011).

  53. 53.

    et al. Functional differences in engineered myocardium from embryonic stem cell-derived versus neonatal cardiomyocytes. Stem Cell Reports 1, 387–396 (2013).

  54. 54.

    et al. Microfluidic bioreactor for dynamic regulation of early mesodermal commitment in human pluripotent stem cells. Lab Chip 13, 355–364 (2013).

  55. 55.

    et al. Human neural stem cell growth and differentiation in a gradient generating microfluidic device. Lab Chip 5, 401–406 (2005).

  56. 56.

    et al. A microfluidic array for quantitative analysis of human neural stem cell self-renewal and differentiation in three-dimensional hypoxic microenvironment. Biomaterials 34, 6607–6614 (2013).

  57. 57.

    , , , & Micropatterned three-dimensional hydrogel system to study human endothelial-mesenchymal stem cell interactions. J. Tissue Eng. Regen. Med. 4, 205–215 (2010).

  58. 58.

    et al. Three-dimensional extracellular matrix-mediated neural stem cell differentiation in a microfluidic device. Lab Chip 12, 2305–2308 (2012).

  59. 59.

    et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 26, 443–452 (2008).

  60. 60.

    et al. A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells. Nat. Cell Biol. 15, 1098–1106 (2013).

  61. 61.

    et al. Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance. Circ. Res. 107, 340–347 (2010).

  62. 62.

    et al. High-throughput identification of small molecules for human hepatocyte expansion and iPS differentiation. Nat. Chem. Biol. 9, 514–520 (2013).

  63. 63.

    et al. The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors. Biotechnol. Prog. 20, 338–345 (2004).

  64. 64.

    , , , & Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human. Biochem. Pharmacol. 78, 625–632 (2009).

  65. 65.

    et al. Metabolic characterization of primary rat hepatocytes cultivated in parallel microfluidic biochips. J. Pharm. Sci. 102, 3264–3276 (2013).

  66. 66.

    , , & Zonation related function and ubiquitination regulation in human hepatocellular carcinoma cells in dynamic vs. static culture conditions. BMC Genomics 13, 54 (2012).

  67. 67.

    & Formation of steady-state oxygen gradients in vitro: application to liver zonation. Biotechnol. Bioeng. 82, 253–262 (2003).

  68. 68.

    et al. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr. Drug Metab. 6, 569–591 (2005).

  69. 69.

    et al. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip 9, 2026–2035 (2009).

  70. 70.

    , , , & A microfluidic hepatic coculture platform for cell-based drug metabolism studies. Biochem. Pharmacol. 79, 1036–1044 (2010).

  71. 71.

    , , , & Development of a renal microchip for in vitro distal tubule models. Biotechnol. Prog. 23, 1245–1253 (2007).

  72. 72.

    et al. Analysis of transcriptomic and proteomic profiles demonstrates improved Madin-Darby canine kidney cell function in a renal microfluidic biochip. Biotechnol. Prog. 28, 474–484 (2012).

  73. 73.

    et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr. Biol. (Camb) 5, 1119–1129 (2013).

  74. 74.

    , , & Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity. Biotechnol. Bioeng. 104, 193–205 (2009).

  75. 75.

    et al. Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems. Proc. Natl. Acad. Sci. USA 104, 18886–18891 (2007).

  76. 76.

    et al. Pulmonary tissue engineering using dual-compartment polymer scaffolds with integrated vascular tree. Int. J. Artif. Organs. 32, 701–710 (2009).

  77. 77.

    et al. Epithelium damage and protection during reopening of occluded airways in a physiologic microfluidic pulmonary airway model. Biomed. Microdevices 13, 731–742 (2011).

  78. 78.

    , , & Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. Lab Chip 11, 4165–4173 (2011).

  79. 79.

    , , , & Metabolic monitoring of the electrically stimulated single heart cell within a microfluidic platform. Lab Chip 6, 1424–1431 (2006).

  80. 80.

    et al. Microfluidic cardiac cell culture model (mCCCM). Anal. Chem. 82, 7581–7587 (2010).

  81. 81.

    et al. Muscle on a chip: in vitro contractility assays for smooth and striated muscle. J. Pharmacol. Toxicol. Methods 65, 126–135 (2012).

  82. 82.

    , , , & Patterning osteogenesis by inducible gene expression in microfluidic culture systems. Integr. Biol. (Camb) 3, 39–47 (2011).

  83. 83.

    , , , & Patient-specific 3D microfluidic tissue model for multiple myeloma. Tissue Eng. Part C Methods doi:10.1089/ten.tec.2013.0490 (17 January 2014).

  84. 84.

    et al. Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro. Nat. Methods 11, 663–669 (2014).

  85. 85.

    , , , & Integration and application of vitrified collagen in multilayered microfluidic devices for corneal microtissue culture. Lab Chip 9, 3221–3227 (2009).

  86. 86.

    , & Characterization of microfluidic human epidermal keratinocyte culture. Cytotechnology 56, 197–207 (2008).

  87. 87.

    et al. Endothelialized networks with a vascular geometry in microfabricated poly(dimethyl siloxane). Biomed. Microdevices 6, 269–278 (2004).

  88. 88.

    , , , & Three-dimensional co-cultures of human endothelial cells and embryonic stem cell-derived pericytes inside a microfluidic device. Lab Chip 13, 3562–3568 (2013).

  89. 89.

    et al. Glia co-culture with neurons in microfluidic platforms promotes the formation and stabilization of synaptic contacts. Lab Chip 13, 3008–3021 (2013).

  90. 90.

    , , , & Neuromuscular junction in a microfluidic device. Conf. IEEE Eng. Med. Biol. Soc. 2013, 2833–2835 (2013).

  91. 91.

    , , , & Efficient generation of schwann cells from human embryonic stem cell-derived neurospheres. Stem Cell Rev. 7, 394–403 (2011).

  92. 92.

    , , , & Murine in vitro model of the blood-brain barrier for evaluating drug transport. Eur. J. Pharm. Sci. 42, 148–155 (2011).

  93. 93.

    , & The effect of astrocytes on the induction of barrier properties in aortic endothelial cells. Biotechnol. Prog. 27, 1137–1145 (2011).

  94. 94.

    et al. A modular approach to create a neurovascular unit-on-a-chip. Lab Chip 13, 542–553 (2013).

  95. 95.

    et al. The use of micropatterned co-cultures to detect compounds that cause drug induced liver injury in humans. Toxicol. Sci. 132, 107–117 (2013).

  96. 96.

    & Microscale culture of human liver cells for drug development. Nat. Biotechnol. 26, 120–126 (2008).

  97. 97.

    , et al. A biophysical indicator of vaso-occlusive risk in sickle cell disease. Sci. Transl. Med. 4, 123ra26 (2012).

  98. 98.

    , , & Induction of epithelial-to-mesenchymal transition in proximal tubular epithelial cells on microfluidic devices. Biomaterials 35, 1390–1401 (2014).

  99. 99.

    et al. Atherosclerotic geometries exacerbate pathological thrombus formation poststenosis in a von Willebrand factordependent manner. Proc. Natl. Acad. Sci. USA 110, 1357–1362 (2013).

  100. 100.

    et al. Muscular thin films for building actuators and powering devices. Science 317, 1366–1370 (2007).

  101. 101.

    et al. Anisotropic stretch-induced hypertrophy in neonatal ventricular myocytes micropatterned on deformable elastomers. Biotechnol. Bioeng. 81, 578–587 (2003).

  102. 102.

    , , , & Recapitulating maladaptive, multiscale remodeling of failing myocardium on a chip. Proc. Natl. Acad. Sci. USA 110, 9770–9775 (2013).

  103. 103.

    et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 20, 616–623 (2014).

  104. 104.

    et al. Micropatterned cell-cell interactions enable functional encapsulation of primary hepatocytes in hydrogel microtissues. Tissue Eng. (in the press).

  105. 105.

    , & Multiplexed, high-throughput analysis of 3D microtissue suspensions. Integr. Biol. (Camb) 2, 517–527 (2010).

  106. 106.

    , , & Mechanisms of tumor cell extravasation in an in vitro microvascular network platform. Integr. Biol. (Camb) 5, 1262–1271 (2013).

  107. 107.

    , , , & In vitro perfused human capillary networks. Tissue Eng. Part C Methods 19, 730–737 (2013).

  108. 108.

    , , & Tubeless microfluidic angiogenesis assay with three-dimensional endothelial-lined microvessels. Biomaterials 34, 1471–1477 (2013).

  109. 109.

    , , , & A microfluidic platform for generating large-scale nearly identical human microphysiological vascularized tissue arrays. Lab Chip 13, 2990–2998 (2013).

  110. 110.

    et al. Astrocyte-neuron co-culture on microchips based on the model of SOD mutation to mimic ALS. Integr. Biol. (Camb) 5, 964–975 (2013).

  111. 111.

    et al. Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integr. Biol. (Camb) 3, 439–450 (2011).

  112. 112.

    , , & Enabling screening in 3D microenvironments: probing matrix and stromal effects on the morphology and proliferation of T47D breast carcinoma cells. Integr. Biol. (Camb) 5, 631–640 (2013).

  113. 113.

    , , , & Hormonally responsive breast cancer cells in a microfluidic co-culture model as a sensor of microenvironmental activity. Integr. Biol. (Camb) 5, 807–816 (2013).

  114. 114.

    et al. Microfluidic endothelium for studying the intravascular adhesion of metastatic breast cancer cells. PLoS ONE 4, e5756 (2009).

  115. 115.

    et al. Study on invadopodia formation for lung carcinoma invasion with a microfluidic 3D culture device. PLoS ONE 8, e56448 (2013).

  116. 116.

    et al. Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function. Proc. Natl. Acad. Sci. USA 109, 13515–13520 (2012).

  117. 117.

    , , , & In vitro model of tumor cell extravasation. PLoS ONE 8, e56910 (2013).

  118. 118.

    & A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers. Biotechnol. Bioeng. 103, 187–198 (2009).

  119. 119.

    & A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs. Lab Chip 9, 1385–1394 (2009).

  120. 120.

    et al. Metabolomics-on-a-chip of hepatotoxicity induced by anticancer drug flutamide and Its active metabolite hydroxyflutamide using HepG2/C3a microfluidic biochips. Toxicol. Sci. 132, 8–20 (2013).

  121. 121.

    et al. Metabolomics-on-a-chip and predictive systems toxicology in microfluidic bioartificial organs. Anal. Chem. 84, 1840–1848 (2012).

  122. 122.

    et al. Investigation of ifosfamide nephrotoxicity induced in a liver-kidney co-culture biochip. Biotechnol. Bioeng. 110, 597–608 (2013).

  123. 123.

    et al. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol. Toxicol. 28, 69–87 (2012).

  124. 124.

    , & Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab. Dispos. 31, 1035–1042 (2003).

  125. 125.

    et al. Evaluation of seven drug metabolisms and clearances by cryopreserved human primary hepatocytes cultivated in microfluidic biochips. Xenobiotica 43, 140–152 (2013).

  126. 126.

    et al. A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening. Int. J. Pharm. 408, 67–75 (2011).

  127. 127.

    et al. Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac. Drug Metab. Dispos. 41, 2024–2032 (2013).

  128. 128.

    et al. Evaluation of a liver microfluidic biochip to predict in vivo clearances of seven drugs in rats. J. Pharm. Sci. 103, 706–718. (2014).

  129. 129.

    et al. TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling. Circ. Res. 104, 1123–1130 (2009).

  130. 130.

    et al. An orally active TRPV4 channel blocker presents and resolves pulmonary edema induced by heart failure. Sci. Transl. Med. 4, 159ra148 (2012).

  131. 131.

    et al. Microfluidic single cell arrays to interrogate signalling dynamics of individual, patient-derived hematopoietic stem cells. Lab Chip 9, 2659–2664 (2009).

  132. 132.

    et al. Application of a microfluidic chip-based 3D co-culture to test drug sensitivity for individualized treatment of lung cancer. Biomaterials 34, 4109–4117 (2013).

  133. 133.

    , & In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol. Sci. 84, 110–119 (2005).

  134. 134.

    , , & Effect of cell-cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and non parenchymal cells. FASEB J. 13, 1883–1900 (1999).

  135. 135.

    et al. Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance. Proc. Natl. Acad. Sci. USA 106, 15714–15719 (2009).

  136. 136.

    et al. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue Eng. Part A 18, 910–919 (2012).

  137. 137.

    & Skeletal muscle atrophy in bioengineered skeletal muscle: a new model system. Tissue Eng. Part A 19, 2147–2155 (2013).

  138. 138.

    , , , & Tissue engineering the mechanosensory circuit of the stretch reflex arc: sensory neuron innervation of intrafusal muscle fibers. Biomaterials 31, 8218–8227 (2010).

  139. 139.

    et al. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc. Natl. Acad. Sci. USA 107, 3141–3145 (2010).

  140. 140.

    et al. A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax. Cell Host Microbe 14, 104–115 (2013).

  141. 141.

    et al. A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. Lab Chip 13, 3538–3547 (2013).

  142. 142.

    et al. Perfused multiwell plate for 3D liver tissue engineering. Lab Chip 10, 51–58 (2010).

  143. 143.

    et al. Design and prototyping of a chip-based multi-micro-organoid culture system for substance testing, predictive to human (substance) exposure. J. Biotechnol. 148, 70–75 (2010).

  144. 144.

    et al. Skin and hair on-a-chip: in vitro skin models versus ex vivo tissue maintenance with dynamic perfusion. Lab Chip 13, 3555–3561 (2013).

  145. 145.

    et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip 13, 3588–3598 (2013).

  146. 146.

    et al. A microfluidic platform for probing small artery structure and function. Lab Chip 10, 2341–2349 (2010).

  147. 147.

    , , & A microfluidic device designed to induce media flow throughout pancreatic islets while limiting shear-induced damage. Lab Chip 13, 4374–4384 (2013).

  148. 148.

    , , & A microfluidic approach for in vitro assessment of interorgan interactions in drug metabolism using intestinal and liver slices. Lab Chip 10, 2778–2786 (2010).

  149. 149.

    et al. A microfluidic microelectrode array for simultaneous electrophysiology, chemical stimulation, and imaging of brain slices. Lab Chip 13, 527–535 (2013).

  150. 150.

    Idiosyncratic drug hepatotoxicity. Nat. Rev. Drug Discov. 4, 489 (2005).

  151. 151.

    et al. Clear castable polyurethane elastomer for fabrication of microfluidic devices. Lab Chip 13, 3956–3964 (2013).

  152. 152.

    et al. Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments. Lab Chip 9, 3185–3192 (2009).

  153. 153.

    , & Integration of in silico and in vitro platforms for pharmacokinetic-pharmacodynamic modeling. Expert Opin. Drug Metab. Toxicol. 6, 1063–1081 (2010).

  154. 154.

    et al. Scaling and systems biology for integrating multiple organsona-Chip. Lab Chip 13, 3496–3511 (2013).

  155. 155.

    et al. Engineering challenges for instrumenting and controlling integrated organ-on-chip systems. IEEE Trans. Biomed. Eng. 60, 682–690 (2013).

  156. 156.

    , & A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip. Lab Chip 10, 446–455 (2010).

Download references

Acknowledgements

We thank H. Fleming, S. Khetani, D. Levner, G. Hamilton and T. Bahinski for their helpful input. This work was supported by grants from the Defense Advanced Research Projects Agency (DARPA) (W911NF-12-2-0036), the FDA (HHSF223201310079C), the US National Institutes of Health (UH3 EB017103, R01 DK85713, R01 EB008396), Bill and Melinda Gates Foundation (OPP1023607, OPP1086223) and the Wyss Institute for Biologically Inspired Engineering at Harvard University. S.N.B. is an investigator of the Howard Hughes Medical Institute; D.E.I. is a recipient of a US Department of Defense (DoD) Breast Cancer Innovator Award (BC074986).

Author information

Affiliations

  1. Department of Electrical Engineering & Computer Science, Koch Institute and Institute for Medical Engineering and Science, Massachusetts Institute of Technology and Broad Institute, Cambridge, Massachusetts, USA.

    • Sangeeta N Bhatia
  2. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.

    • Sangeeta N Bhatia
  3. Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts, USA.

    • Donald E Ingber
  4. Vascular Biology Program, Departments of Pathology & Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

    • Donald E Ingber
  5. School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA.

    • Donald E Ingber

Authors

  1. Search for Sangeeta N Bhatia in:

  2. Search for Donald E Ingber in:

Competing interests

S.N.B. is a co-founder of Hepregen Corporation, and D.E.I. is a founder of Emulate Inc.

Corresponding author

Correspondence to Donald E Ingber.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nbt.2989

Further reading